Levemir Related Clinical Trials
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-Life" Usage in Germany [Recruiting]
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus [Recruiting]
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus [Recruiting]
Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics [Recruiting]
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes [Completed]
Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus [Recruiting]
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes [Recruiting]
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir). [Recruiting]
Observational Study to Evaluate the Safety of Levemir® in Diabetes [Recruiting]
Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes [Recruiting]
Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes [Recruiting]
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-Related Diabetes (CFRD) [Recruiting]
Observational Study on Safety of Self-Titration of Once Daily Levemir® [Recruiting]
Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes [Recruiting]
Observational Study of Patients With Diabetes Using Levemir® FlexPen® [Recruiting]
Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes [Recruiting]
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes [Recruiting]
Comparing the Metabolic Control of Once to Twice-Daily Insulin Detemir Injections [Not yet recruiting]
Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naĂŻve Subjects With Type 2 Diabetes [Not yet recruiting]
Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes
Comparing Efficacy of Levemir on Blood Glucose Control Between Two Treatment Regimens in Subjects With Type 2 Diabetes in Korea [Recruiting]
Comparison of Insulin Detemir and NPH Insulin in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily. The Pediatric Mixing Trial. [Recruiting]
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension Trial [Recruiting]
Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes [Recruiting]
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes [Recruiting]
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin [Recruiting]
Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine [Recruiting]
Efficacy and Safety of Insulin Detemir Versus NPH Insulin in Pregnant Women With Type 1 Diabetes [Recruiting]
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin [Recruiting]
Insulin Detemir Action in Cerebro [Not yet recruiting]
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes [Active, not recruiting]
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes [Recruiting]
Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients [Recruiting]
Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes [Completed]
An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-Diabetic Treatment [Recruiting]
Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes [Recruiting]
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes [Active, not recruiting]
Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes [Completed]
Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes [Completed]
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes [Completed]
Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes [Completed]
Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes [Completed]
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes [Completed]
The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD [Completed]
Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes [Completed]
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes [Active, not recruiting]
L2T3 (Lantus Versus Levemir Treat-To-Target) [Active, not recruiting]
Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients [Active, not recruiting]
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes [Recruiting]
Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir [Recruiting]
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes [Completed]
Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes [Completed]
Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Recruiting]
The Copenhagen Insulin and Metformin Therapy Trial [Recruiting]
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-Diabetic Agents [Recruiting]
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir [Terminated]
Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes [Recruiting]
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes [Active, not recruiting]
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes - A Comparison of 3 Long-Acting Insulins [Completed]
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes [Completed]
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes [Recruiting]
Efficacy, Safety and Preference Study of a Comparator Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics [Recruiting]
Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes [Active, not recruiting]
Detemir: Role in Type 1 Diabetes [Recruiting]
Sub-Cutaneous Insulin in Hyperglycaemic Emergencies [Withdrawn]
Insulin Analogues and Severe Hypoglycaemia [Recruiting]
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes [Recruiting]
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. [Recruiting]
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes [Terminated]
Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes [Terminated]
|
